Constellium to Appoint Bradley L. Soultz as Special Advisor to the Board of Directors
PARIS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) today announced that Mr. Bradley L. Soultz will be appointed as Special Advisor to the Board of Directors in September 2024. The Board expects to put forward the nomination of Mr. Soultz as a Non-Executive Director at the Company’s Annual General Meeting to be held in 2025.
Mr. Soultz has served as CEO of WillScot Mobile Mini (Nasdaq: WSC) since the merger of WillScot and Mobile Mini in 2020. Prior to becoming WillScot’s President and CEO in 2017, he served as President and CEO of Williams Scotsman (WSII), where he was responsible for the strategic and operational aspects of WSII’s North American business and for helping prepare the company for its reemergence as a public company.
Before joining WSII, Mr. Soultz worked for nine years at Novelis, most recently as Chief Commercial and Strategy Officer. He started his career with Cummins.
A U.S. national, Mr. Soultz has lived both in Europe and North America, and holds a Bachelor of Science Agricultural Engineering from Purdue University.
About Constellium
Constellium (NYSE: CSTM) is a global sector leader that develops innovative, value-added aluminium products for a broad scope of markets and applications, including aerospace, automotive and packaging. Constellium generated €7.2 billion of revenue in 2023.
www.constellium.com
Media Contacts | |
Investor Relations | Communications |
Jason Hershiser | Delphine Dahan-Kocher |
Phone: +1 443 988-0600 | Phone: +1 443 420 7860 |
investor-relations@constellium.com | delphine.dahan-kocher@constellium.com |
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks